Clinical Trial: Deucravacitinib in PG
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Pyoderma Gangrenosum
Study Type: INTERVENTIONAL
Official Title: Novel Treatment of Pyoderma Gangrenosum With Deucravacitinib
Brief Summary:
The main goal of this study is to see if the study drug called "Deucravacitinib" is safe and effective in treating people with pyoderma gangrenosum (PG).
Read more